Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?


Endothelial progenitor cells (EPCs) are vital for the maintenance and repair of the endothelium. Decreased EPC number and function have been associated with increased cardiovascular (CVD) risk. Patients with diabetes have decreased number of circulating EPCs and decreased EPC function. This may account for some of the increased CVD risk seen in patients… (More)
DOI: 10.1016/j.jdiacomp.2013.04.007


2 Figures and Tables